Products & ServicesEvent: September 8, 2026
Boehringer Ingelheim is inviting experts to propose bold concepts for an autonomous small-molecule synthesis platform encompassing the complete Make phase from reagent handling to delivery of purified compounds.
Published
Signal category
Products & Services
Quote
“We invite experts to propose bold concepts for an autonomous small-molecule synthesis platform that encompasses the complete Make phase, from reagent handling to delivery of purified compounds.”
— Florian Montel|Boehringer Ingelheim team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- Ingelheim am Rhein, DE
- Company size
- 47,439 employees
Our people are our strength. And together with over 54,000 colleagues, we're creating the next breakthrough in the world of healthcare and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint